Project Klinische Studien – BRF117019

Basic data

Acronym:
Klinische Studien
Title:
BRF117019
Duration:
13/11/2014 to 12/11/2016
Abstract / short description:
Open-label, Study in Patients with BRAF V600E-Mutated Rare Cancers with Several Histologies to Investigate the Clinical Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib.

Involved staff

Managers

Faculty of Medicine
University of Tübingen

Local organizational units

General and Molecular Pathology and Pathological Anatomy
Department of Diagnostic Laboratory Medicine
Hospitals and clinical institutes, Faculty of Medicine

Funders

München, Bayern, Germany
Help

will be deleted permanently. This cannot be undone.